Latest Breaking News On - European medicines agency ema - Page 4 : comparemela.com

EMA CONTRADICTS HIS VACCINE’S EXPERT: RARE THROMBOSIS! BUSINESS MUST CONTINUE: WOMEN CAN EVEN DIED! The “benefits” of the AstraZeneca vaccine “outweigh the risks”. The EMA reiterates this in a note at the end of its evaluation. “Rare events” of cerebral thrombosis “are very rare side effects” of the AstraZeneca vaccine. This was reported by the EMA in a note. “EMA reminds healthcare professionals and people receiving the vaccine to remain aware of the possibility that very rare cases of blood clots combined with low blood platelet levels occur within 2 weeks of vaccination,” writes the European Agency in the note. “So far, the majority of reported cases have occurred in women under the age of 60 within 2 weeks of vaccination. Based on the evidence currently available, specific risk factors have not been confirmed.” This is what the Italian press agency ANSA, which has always been a media sponsor of the AstraZeneca vaccine, half-Italian (read below to unde

United kingdomMarco cavaleriLazio nicola zingarettiOxford astrazenecaFabio giuseppe carlo carisioBill gatesHealth products regulatory agencyReseau internationalUniversity of oxfordEuropean medicines agency emaDemocratic partyEuropean medicines agencyItalian undersecretary of health pierpaolo sileriEuropean agencyHealth roverto speranzaCatholic university of the sacred heart